CEACAM5 and colorectal carcinoma: The authors found that a CTC count > 3, CEA > 5 ng/ml, and the presence of CTC clusters were all individually associated with recurrence in stage III CRC patients (odds ratios of 2.6, 5.1, and 3.2, respectively).